 |
|
| CLUSTERIN, PART B, 105
| |
| | |
|
|
To order this title, and for more information, click here
Saverio Bettuzzi
Sabina Pucci
Included in series
Advances in Cancer Research,
Audience
Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.
Contents
1. CLU and prostate cancer.
S. Bettuzzi and F. Rizzi
2. The role of Clusterin
(CLU) in malignant transformation and drug resistance in breast carcinomas
Maximino Redondo; Teresa Tellez; Mar a Jose
Roldan.
3. CLU and COLON CANCER
The dual face of CLU: from normal to malignant phenotype
Mazzarelli P. Pucci S. Spagnoli L.G.
4. Clusterin (CLU) and lung cancer
F. Panico*, 2F. Rizzi*, 1L.M. Fabbri, and 2S. Bettuzzi , 1F. Luppi
5. CLUSTERIN AND CHEMORESISTANCE
Julie Y. Djeu and Sheng Wei
6.
CLU "in and out": looking for a link
Pucci S.1 , Mazzarelli P. 1 , Nucci C. 2, Ricci F.
2, Spagnoli L.G. 1
7. Regulation of CLU gene expression by oncogenes and epigenetic
factors: Implications
for tumorigenesis
Arturo Sala, 2 * Saverio Bettuzzi, 3 Sabina Pucci, 1 Olesya
Chayka, 4 Michael Dews, and 4 Andrei Thomas-Tikhonenko
8. CONCLUSIONS AND PERSPECTIVES
Saverio Bettuzzi
| Bibliographic details |
Hardbound, 350 pages, publication date: NOV-2009
ISBN-13: 978-0-12-381429-6
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 75
USD 150
EUR 110
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 30 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company